LPL Financial
FBIO icon

LPL Financial’s Fortress Biotech FBIO Stock Holding History

LPL Financial’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,467
Closed -$10.7K – 4829
2023
Q3 		$10.7K Buy
+2,467
New +$16.9K ﹤0.01% 4644
2023
Q2 		– Sell
-1,333
Closed -$16.4K – 4616
2023
Q1 		$16.4K Buy
+1,333
New +$15.9K ﹤0.01% 4427
2021
Q2 		– Sell
-2,428
Closed -$129K – 4248
2021
Q1 		$129K Sell
2,428
-309
-11% -$17.4K ﹤0.01% 3875
2020
Q4 		$130K Sell
2,737
-7,418
-73% -$321K ﹤0.01% 3639
2020
Q3 		$615K Buy
+10,155
New +$517K ﹤0.01% 2307

Other funds holding FBIO

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

LPL Financial's FBIO Position: Q4 2023 in Review

LPL Financial sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 2,467 shares — an estimated $10.7K sold.

LPL Financial first reported a position in FBIO in Q3 2020 and held it in 5 quarters. The position peaked at $615K in Q3 2020. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

  • LPL Financial reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
  • LPL Financial sold 2,467 Fortress Biotech shares in Q4 2023, an estimated $10.7K.
  • LPL Financial first reported a position in Fortress Biotech in Q3 2020 and held it in 5 quarters.
  • LPL Financial's Fortress Biotech position peaked at $615K in Q3 2020.
  • 42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on LPL Financial's 13F filing for Q4 2023, filed 14 Feb 2024.